Alexander S Parker, PhD
Professor; Senior Associate Dean For Research
Department:
Dean's Office – Administration
Business Email:
alexander.parker@jax.ufl.edu
Teaching Profile
Courses Taught
2019-2021
PHC6598 Foundations in Precision Medicine: Genetic Epidemiology
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-6820-274X
Publications
Academic Articles
2024
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
Blood.
143(17):1752-1757
[DOI] 10.1182/blood.2023022180.
[PMID] 38194687.
2024
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis.
Blood advances.
8(9):2118-2129
[DOI] 10.1182/bloodadvances.2023012242.
[PMID] 38359367.
2023
Association of Medicaid expansion with 2-year survival and time to treatment initiation in gastrointestinal cancer patients: A National Cancer Database study.
Journal of surgical oncology.
128(8):1285-1301
[DOI] 10.1002/jso.27456.
[PMID] 37781956.
2023
Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes.
Cancer control : journal of the Moffitt Cancer Center.
30
[DOI] 10.1177/10732748231197878.
[PMID] 37703814.
2023
Impact of Medicaid Expansion on Stage at Diagnosis for US Adults with Pancreatic Cancer: a Population-Based Study.
Journal of racial and ethnic health disparities.
10(6):2826-2835
[DOI] 10.1007/s40615-022-01459-4.
[PMID] 36596980.
2022
Frailty and risk of mortality in older cancer survivors and adults without a cancer history: Evidence from the National Health and Nutrition Examination Survey, 1999-2014.
Cancer.
128(15):2978-2987
[DOI] 10.1002/cncr.34258.
[PMID] 35608563.
2022
Impact of Medicaid Expansion on Pancreatic Cancer: An Examination of Sociodemographic Disparity in 1-Year Survival.
Journal of the American College of Surgeons.
234(1):75-84
[DOI] 10.1097/XCS.0000000000000018.
[PMID] 35213464.
2022
Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning.
Cancer research.
82(15):2792-2806
[DOI] 10.1158/0008-5472.CAN-21-2318.
[PMID] 35654752.
2022
Novel plasma glycoprotein biomarkers predict progression-free survival in surgically resected clear cell renal cell carcinoma.
Urologic oncology.
40(4):168.e11-168.e19
[DOI] 10.1016/j.urolonc.2021.12.005.
[PMID] 35148948.
2021
Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma.
Urologic oncology.
39(2):135.e1-135.e8
[DOI] 10.1016/j.urolonc.2020.08.028.
[PMID] 33309297.
2021
Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer.
Clinical epigenetics.
13(1)
[DOI] 10.1186/s13148-020-00998-z.
[PMID] 33461589.
2021
Lower disease control rates and survival outcomes among Blacks with pharyngeal squamous cell carcinomas compared with Whites: a retrospective analysis at the University of Florida.
Cancer causes & control : CCC.
32(11):1269-1278
[DOI] 10.1007/s10552-021-01477-3.
[PMID] 34259972.
2020
Bioimpedance Spectroscopy for Assessment of Breast Cancer-Related Lymphedema: A Systematic Review.
Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses.
40(2):86-90
[DOI] 10.1097/PSN.0000000000000306.
[PMID] 32459756.
2020
Breast cancer in women: a descriptive analysis of the national cancer database.
Acta bio-medica : Atenei Parmensis.
91(2):332-341
[DOI] 10.23750/abm.v91i2.8399.
[PMID] 32420970.
2020
Chronic Tenosynovitis of the Upper Extremities Caused by Mycobacterium kansasii : A Clinical Case and Systematic Review of Literature.
Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India.
53(1):25-35
[DOI] 10.1055/s-0040-1709377.
[PMID] 32367915.
2020
Influence of gene expression on survival of clear cell renal cell carcinoma.
Cancer medicine.
9(22):8662-8675
[DOI] 10.1002/cam4.3475.
[PMID] 32986937.
2020
National Analysis of Patients With Ulcerated Melanoma in the United States.
Anticancer research.
40(2):1055-1058
[DOI] 10.21873/anticanres.14042.
[PMID] 32014953.
2019
Delay to Colectomy and Survival for Patients Diagnosed with Colon Cancer.
Journal of investigative surgery : the official journal of the Academy of Surgical Research.
32(4):350-357
[DOI] 10.1080/08941939.2017.1421732.
[PMID] 29351008.
2019
Disparity on Unplanned Readmission in Melanoma Patients: A National Cancer Database Analysis.
Anticancer research.
39(12):6877-6880
[DOI] 10.21873/anticanres.13906.
[PMID] 31810956.
2019
Influence of Facility Characteristics on Access to Breast Reconstruction: A 12-Year National Cancer Database Analysis.
Anticancer research.
39(12):6881-6885
[DOI] 10.21873/anticanres.13907.
[PMID] 31810957.
2019
Osteosarcoma of the Upper Extremities: A National Analysis of the US Population.
Anticancer research.
39(10):5663-5668
[DOI] 10.21873/anticanres.13763.
[PMID] 31570464.
2019
Survival Disparities in Male Patients With Breast Cancer.
Anticancer research.
39(10):5669-5674
[DOI] 10.21873/anticanres.13764.
[PMID] 31570465.
2019
Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma.
Translational cancer research.
8(Suppl 4):S397-S403
[DOI] 10.21037/tcr.2019.06.36.
[PMID] 35117117.
2019
The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.
PLoS medicine.
16(1)
[DOI] 10.1371/journal.pmed.1002724.
[PMID] 30605491.
2019
What Factors Define Limb Salvage or Amputation Surgery in Osteosarcoma of the Upper Extremities?
Anticancer research.
39(12):6807-6811
[DOI] 10.21873/anticanres.13896.
[PMID] 31810946.
2019
Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
Anticancer research.
39(9):5027-5031
[DOI] 10.21873/anticanres.13693.
[PMID] 31519610.
2018
Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.
International journal of cancer.
142(4):747-756
[DOI] 10.1002/ijc.31103.
[PMID] 29023769.
2018
Prevalence of Nephrolithiasis in Patients with Chronic Liver Disease: A Case-Control Study.
Journal of clinical and experimental hepatology.
8(4):375-379
[DOI] 10.1016/j.jceh.2018.01.004.
[PMID] 30563998.
2018
The Determinants of Palliative Care Use in Patients With Colorectal Cancer: A National Study.
The American journal of hospice & palliative care.
35(10):1295-1303
[DOI] 10.1177/1049909118765092.
[PMID] 29580075.
2017
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.
BMC urology.
17(1)
[DOI] 10.1186/s12894-017-0209-3.
[PMID] 28327121.
2017
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
European urology.
71(6):979-985
[DOI] 10.1016/j.eururo.2016.11.018.
[PMID] 27899233.
2017
Coffee consumption and risk of renal cell carcinoma.
Cancer causes & control : CCC.
28(8):857-866
[DOI] 10.1007/s10552-017-0913-z.
[PMID] 28647866.
2017
Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell Sarcoma.
Rare tumors.
9(2)
[DOI] 10.4081/rt.2017.6834.
[PMID] 28975018.
2017
GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.
The British journal of radiology.
90(1075)
[DOI] 10.1259/bjr.20170174.
[PMID] 28486040.
2017
Genome-wide association study identifies multiple risk loci for renal cell carcinoma.
Nature communications.
8
[DOI] 10.1038/ncomms15724.
[PMID] 28598434.
2017
Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
35(32):3706-3713
[DOI] 10.1200/JCO.2017.73.3238.
[PMID] 28976794.
2017
Timing interval from peri-prostatic block to biopsy impacts procedural pain.
The Canadian journal of urology.
24(3):8795-8801
[PMID] 28646934.
2016
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer.
PloS one.
11(3)
[DOI] 10.1371/journal.pone.0151785.
[PMID] 26986977.
2016
Author Reply.
Urology.
89:61-2
[DOI] 10.1016/j.urology.2015.10.039.
[PMID] 26797576.
2016
Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.
The Journal of urology.
195(1):180-7
[DOI] 10.1016/j.juro.2015.07.113.
[PMID] 26300218.
2016
Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
Clinical imaging.
40(5):902-6
[DOI] 10.1016/j.clinimag.2016.04.008.
[PMID] 27183138.
2016
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
29(1):34-42
[DOI] 10.1038/modpathol.2015.123.
[PMID] 26516698.
2016
Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival.
Urology.
89:54-60
[DOI] 10.1016/j.urology.2015.10.034.
[PMID] 26723183.
2016
Radical Prostatectomy Trends in the United States: 1998 to 2011.
Mayo Clinic proceedings.
91(1):10-6
[DOI] 10.1016/j.mayocp.2015.09.018.
[PMID] 26763510.
2016
Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death.
European urology focus.
2(6):608-615
[DOI] 10.1016/j.euf.2016.03.008.
[PMID] 28723492.
2015
A Multidisciplinary Biospecimen Bank of Renal Cell Carcinomas Compatible with Discovery Platforms at Mayo Clinic, Scottsdale, Arizona.
PloS one.
10(7)
[DOI] 10.1371/journal.pone.0132831.
[PMID] 26181416.
2015
Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.
Urologic oncology.
33(2):68.e17-23
[DOI] 10.1016/j.urolonc.2014.07.019.
[PMID] 25175426.
2015
Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.
Psycho-oncology.
24(4):451-7
[DOI] 10.1002/pon.3605.
[PMID] 24953309.
2015
Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma–implications on the T-classification system.
Journal of surgical oncology.
111(4):483-4
[DOI] 10.1002/jso.23841.
[PMID] 25492622.
2015
Comparison of patient-reported quality of life outcome questionnaire response rates between patients treated surgically for renal cell carcinoma and prostate carcinoma.
BMC urology.
15
[DOI] 10.1186/s12894-015-0057-y.
[PMID] 26126615.
2015
Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.
Urologic oncology.
33(1):23.e9-23.e14
[DOI] 10.1016/j.urolonc.2014.10.014.
[PMID] 25465300.
2015
Prospective evaluation of the association of adherent perinephric fat with perioperative outcomes of robotic-assisted partial nephrectomy.
Urology.
85(4):836-42
[DOI] 10.1016/j.urology.2014.12.017.
[PMID] 25669734.
2015
Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature.
Rare tumors.
7(1)
[DOI] 10.4081/rt.2015.5719.
[PMID] 25918615.
2015
Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.
Mayo Clinic proceedings.
90(3):366-71
[DOI] 10.1016/j.mayocp.2015.01.001.
[PMID] 25659636.
2015
Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
36(10):7431-7
[DOI] 10.1007/s13277-015-3459-2.
[PMID] 25900876.
2014
ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma.
BMC urology.
14
[DOI] 10.1186/1471-2490-14-14.
[PMID] 24479813.
2014
Correlation of radiographic renal cell carcinoma tumor volume utilizing computed tomography and magnetic resonance imaging compared with pathological tumor volume.
Scandinavian journal of urology.
48(5):453-9
[DOI] 10.3109/21681805.2013.876551.
[PMID] 24990768.
2014
Evaluation of awareness of risk factors for kidney cancer among patients presenting to a urology clinic.
Scandinavian journal of urology.
48(3):239-44
[DOI] 10.3109/21681805.2013.863803.
[PMID] 24328689.
2014
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
23(9):1804-12
[DOI] 10.1158/1055-9965.EPI-14-0029.
[PMID] 24920641.
2014
Genomic medicine and incidental findings: balancing actionability and patient autonomy.
Mayo Clinic proceedings.
89(6):718-21
[DOI] 10.1016/j.mayocp.2014.04.008.
[PMID] 24943691.
2014
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.
European urology.
66(5):929-35
[DOI] 10.1016/j.eururo.2013.12.017.
[PMID] 24388441.
2014
Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.
PloS one.
9(6)
[DOI] 10.1371/journal.pone.0096705.
[PMID] 24896845.
2014
Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma.
Cancer.
120(7):1059-67
[DOI] 10.1002/cncr.28521.
[PMID] 24382589.
2014
MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma.
Proteomics.
14(7-8):924-35
[DOI] 10.1002/pmic.201300434.
[PMID] 24497498.
2014
Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy.
European urology.
66(6):1165-71
[DOI] 10.1016/j.eururo.2014.08.054.
[PMID] 25192968.
2014
Prospective evaluation of 24-hour urine profiles following bariatric surgery in a modern comprehensive care bariatric clinic.
Clinical nephrology.
81(5):331-7
[DOI] 10.5414/CN108154.
[PMID] 24495903.
2014
Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.
European urology.
66(5):e90-1
[DOI] 10.1016/j.eururo.2014.05.009.
[PMID] 24877662.
2014
Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.
Carcinogenesis.
35(4):822-7
[DOI] 10.1093/carcin/bgt485.
[PMID] 24374825.
2013
Age-period-cohort analysis of renal cell carcinoma in United States adults.
Urology.
82(1):43-7
[DOI] 10.1016/j.urology.2013.02.065.
[PMID] 23706585.
2013
Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.
BMC urology.
13
[DOI] 10.1186/1471-2490-13-52.
[PMID] 24148752.
2013
Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy.
Current urology reports.
14(1):26-31
[DOI] 10.1007/s11934-012-0292-7.
[PMID] 23184624.
2013
Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer.
ISRN oncology.
2013
[DOI] 10.1155/2013/239241.
[PMID] 23606986.
2013
Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
Psycho-oncology.
22(6):1328-35
[DOI] 10.1002/pon.3138.
[PMID] 22855322.
2013
Inverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinoma.
Cancer immunology research.
1(6):378-85
[DOI] 10.1158/2326-6066.CIR-13-0042.
[PMID] 24778130.
2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer.
Journal of radiation oncology.
2(3):309-314
[PMID] 24073305.
2013
Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume.
Scandinavian journal of urology.
47(6):472-5
[DOI] 10.3109/21681805.2013.814071.
[PMID] 23883351.
2013
Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery.
Journal of the American College of Surgeons.
216(3):380-9; quiz 511
[DOI] 10.1016/j.jamcollsurg.2012.11.004.
[PMID] 23266421.
2012
Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.
Journal of immunotherapy (Hagerstown, Md. : 1997).
35(9):711-5
[DOI] 10.1097/CJI.0b013e3182742c27.
[PMID] 23090080.
2012
Determination of ureter stent appearance on dual-energy computed tomography scan.
Urology.
80(5):986-9
[DOI] 10.1016/j.urology.2012.07.005.
[PMID] 22921702.
2012
Does left side renal cell carcinoma (RCC) with renal vein/vena cava thrombus predict worse prognosis than equivalent right side RCC tumor thrombus?
International urology and nephrology.
44(4):1005-12
[DOI] 10.1007/s11255-012-0168-2.
[PMID] 22528581.
2012
Dorsal vaginal graft urethroplasty for female urethral stricture disease.
BJU international.
110(11 Pt C):E1090-5
[DOI] 10.1111/j.1464-410X.2012.11233.x.
[PMID] 22594612.
2012
Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer.
The Prostate.
72(16):1757-66
[DOI] 10.1002/pros.22528.
[PMID] 22513981.
2012
Expression of endothelin 2 and localized clear cell renal cell carcinoma.
Human pathology.
43(6):843-9
[DOI] 10.1016/j.humpath.2011.07.011.
[PMID] 22047647.
2012
Impact of fellowship training on one-year outcomes of robotic-assisted prostatectomy.
JSLS : Journal of the Society of Laparoendoscopic Surgeons.
16(2):195-201
[PMID] 23477165.
2012
Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
Urology.
80(1):147-50
[DOI] 10.1016/j.urology.2012.04.013.
[PMID] 22748870.
2012
The effect of robot-assisted laparoscopic prostatectomy on nocturia.
Journal of endourology.
26(7):861-5
[DOI] 10.1089/end.2011.0611.
[PMID] 22332794.
2012
Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
BJU international.
110(7):956-60
[DOI] 10.1111/j.1464-410X.2012.10937.x.
[PMID] 22300498.
2012
Which eligible breast conservation patients choose mastectomy in the setting of newly diagnosed breast cancer?
Annals of surgical oncology.
19(4):1129-36
[DOI] 10.1245/s10434-011-2080-x.
[PMID] 21975859.
2011
Estimation of prostate size in community-dwelling men.
Urology.
77(2):422-6
[DOI] 10.1016/j.urology.2010.05.044.
[PMID] 20800880.
2011
Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer.
International journal of radiation oncology, biology, physics.
79(5):1343-9
[DOI] 10.1016/j.ijrobp.2010.01.061.
[PMID] 20598810.
2011
Evaluation of pancreatic damage after extracorporeal shock wave lithotripsy, percutaneous stone surgery, and ureteroscopy.
Urology.
77(6):1288-91
[DOI] 10.1016/j.urology.2010.08.066.
[PMID] 21215433.
2009
Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
18(2):444-53
[DOI] 10.1158/1055-9965.EPI-08-1002.
[PMID] 19190164.
2009
Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study.
Mayo Clinic proceedings.
84(8):702-6
[DOI] 10.4065/84.8.702.
[PMID] 19648387.
2009
Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.
Cancer.
115(10):2092-103
[DOI] 10.1002/cncr.24263.
[PMID] 19296514.
2009
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.
International journal of radiation oncology, biology, physics.
75(5):1364-70
[DOI] 10.1016/j.ijrobp.2008.12.061.
[PMID] 19464826.
2008
A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.
The Journal of biological chemistry.
283(26):18344-54
[DOI] 10.1074/jbc.M801192200.
[PMID] 18407999.
2008
Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma.
Human pathology.
39(8):1176-84
[DOI] 10.1016/j.humpath.2007.12.009.
[PMID] 18538369.
2008
Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma.
International journal of urology : official journal of the Japanese Urological Association.
15(4):304-8
[DOI] 10.1111/j.1442-2042.2008.01994.x.
[PMID] 18380816.
2008
Evaluation of the impact of body mass index on outcome among renal mass patients treated with hand-assisted laparoscopic radical nephrectomy.
Journal of endourology.
22(2):301-6
[DOI] 10.1089/end.2007.0250.
[PMID] 18294037.
2008
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.
Cancer.
112(7):1471-9
[DOI] 10.1002/cncr.23296.
[PMID] 18260086.
2008
Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies.
Journal of the National Cancer Institute.
100(23):1695-706
[DOI] 10.1093/jnci/djn386.
[PMID] 19033572.
2007
Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies.
Journal of the National Cancer Institute.
99(10):801-10
[PMID] 17505075.
2007
Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies.
International journal of cancer.
121(10):2246-53
[PMID] 17583573.
2007
Re: The epidemiology of renal cell carcinoma.
The Journal of urology.
177(5):1953; author reply 1953-4
[PMID] 17437854.
2007
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
13(16):4740-9
[PMID] 17699851.
2007
Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
13(6):1749-56
[PMID] 17363528.
2006
Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Urology.
68(4):741-6
[PMID] 17070345.
2006
High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
Cancer.
107(1):37-45
[PMID] 16736510.
2006
Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system.
The Journal of urology.
176(3):985-90
[PMID] 16890677.
2006
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Cancer research.
66(7):3381-5
[PMID] 16585157.
2005
Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Clinical cancer research : an official journal of the American Association for Cancer Research.
11(14):5128-39
[PMID] 16033827.
2005
Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
Urology.
65(6):1090-5
[PMID] 15893810.
2004
History of urinary tract infection and risk of renal cell carcinoma.
American journal of epidemiology.
159(1):42-8
[PMID] 14693658.
2004
Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.
Cancer.
100(12):2577-82
[PMID] 15197799.
2003
Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma.
The Journal of urology.
170(2 Pt 1):420-4
[PMID] 12853790.
2003
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Cancer.
97(7):1663-71
[PMID] 12655523.
2003
Smoking cessation and renal cell carcinoma.
Annals of epidemiology.
13(4):245-51
[PMID] 12684190.
2002
Gender, alcohol consumption, and renal cell carcinoma.
American journal of epidemiology.
155(5):455-62
[PMID] 11867357.
2002
High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas.
Human pathology.
33(8):801-5
[PMID] 12203212.
Grants
Jan 2025
ACTIVE
Feasibility and efficacy of CYP2D6 genotype-guided management of opioid analgesics in patients undergoing elective ventral hernia repairs: A pilot pragmatic trial
Role: Co-Investigator
Funding: AMERICAN HERNIA SOCIETY
Jan 2023
ACTIVE
CTOA JAX CRO
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Sep 2022
ACTIVE
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)
Role: Principal Investigator
Funding: MAYO CLINIC
via NATL INST OF HLTH NCI
Apr 2022
– Sep 2024
Point-of-care intervention to address financial toxicity in families facing pediatric cancer
Role: Co-Investigator
Funding: FL DEPT OF HLTH LIVE LIKE BELLA
Feb 2022
ACTIVE
Real-Time and Long-Term Effects of Medical Marijuana on Older Adults: A Prospective Cohort Study
Role: Project Manager
Funding: NATL INST OF HLTH NIA
Jan 2022
– Feb 2023
Study of Monoclonal B-cell Lymphocytosis
Role: Principal Investigator
Funding: MAYO CLINIC
Dec 2021
ACTIVE
Deploying a genomic-medicine risk assessment model for diverse primary care populations and settings
Role: Principal Investigator
Funding: DUKE UNIVERSITY
via NATL INST OF HLTH NHGRI
Dec 2021
– Jul 2023
Access to genetic information leveraging innovative technology (AGILITY) study
Role: Principal Investigator
Funding: RTI INTERNATIONAL
via NATL INST OF HLTH NHGRI
May 2021
– Apr 2024
Biobanking for Breast Cancer Prevention and Disparity Research in Florida
Role: Project Manager
Funding: H LEE MOFFITT CANCER CTR & RES INST
via FL DEPT OF HLTH BANKHEAD-COLEY CANCER RE
Jan 2021
– Dec 2022
Hereditary reflex testing in pancreatic cancer patients
Role: Principal Investigator
Funding: UF FOUNDATION
via SCOTT R MACKENZIE FOUNDATION
Oct 2020
– Dec 2022
NFL/ Cancer Screening during COVID-19 Project 2020 – 2021
Role: Co-Investigator
Funding: AMERICAN CANCER SOCIETY
Sep 2020
ACTIVE
Avalon Fund
Role: Principal Investigator
Funding: UF FOUNDATION
via BOULDER CREST FOUNDATION
Feb 2020
– Jan 2024
Investigating Movement-evoked Pain in osteoArthritic Conditions (IMPACT): An Observational Study to Inform Culturally-Tailored Intervention Development
Role: Project Manager
Funding: NATL INST OF HLTH NIAMS
Sep 2018
ACTIVE
Sparking Advancements in Genomic Medicine?
Role: Project Manager
Funding: NATL INST OF HLTH NHGRI
Sep 2018
– Aug 2023
2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity Center
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
Jul 2018
– Jun 2024
Southeast Enrollment Center (SEEC)
Role: Co-Project Director/Principal Investigator
Funding: UNIV OF MIAMI
via NATL INST OF HLTH OD
Education
PhD, Epidemiology
1996-2000
·
University of Iowa, Iowa City, IA
Contact Details
Emails:
- Business:
- alexander.parker@jax.ufl.edu
Addresses:
- Business Mailing:
-
580 W 8TH ST
JACKSONVILLE FL 32209